Login

BUSINESS TALK YEARLY 2020 By Torn Pracharktam, CEO of Thai Optical Group Pcl 00:00:00

Share On Facebook Share On Twitter

BUSINESS TALK YEARLY 2020 By Torn Pracharktam, CEO of Thai Optical Group Pcl

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Promoting Water Awareness and Technological Development: A Discussion with Acea's CEO | Fabrizio Palermo , CEO, Acea SpA.
00:10:00
investing in innovative early-stage startups across the tech|Rob Coneybeer,Co-Founder and Managing Director,Shasta Ventures
00:10:00
Exclusive Interview with AGI CEO Kevin Andrew Tan | Kevin Andrew L. Tan - Chief Executive Officer & Vice Chairman of Alliance Global
00:10:00
Joey Zwillinger on Supporting Education: Allbirds Co-Founder Speaks at Stiles Hall Event | Joey Zwillinger, CEO, Allbirds Inc.
00:10:00
Rolv Erik Ryssdal, CEO of Schibsted Media Group, presents the company at the NOAH 2013 Conference in London.
00:10:00
Barton Gold: Driving Growth with Resource Expansion and Asset Monetization
00:10:00
30th Jim Hurlock – White & Case Scholarship: Interview with Guillaume Vitrich | Jim Hurlock – White & Case
00:00:00
Cellmid expanding products, portfolio and markets - Maria Halasz , CEO, Cellmid Ltd
00:10:00
Condor Gold: Advancing the La India Project in Nicaragua
00:10:00
Journey through the Enigma: Discovering the Depths of the Mind | Robert Shaak, CEO, ABN AMRO.
00:10:00
CEO Juha Saarela Highlights Key Drivers of Puuilo's Q1 Success in New Fiscal Year | Juha Saarela, CEO, Puuil OYj.
00:10:00
Charting Global Growth: KFIN Tech's Vision with Sreekanth Nadella | Sreekanth Nadella, MD and CEO, KFIN Tech

© 2017 - Neuhu+